Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.
[waldenström macroglobulinemia]
Several
population-based
and
cohort
studies
have
reported
an
increased
risk
of
second
cancers
in
lymphoproliferative
disorders
(
LPDs
)
.
The
cause
of
second
cancers
in
LPDs
is
probably
multifactorial
,
and
the
relative
contribution
of
treatments
,
genetic
predisposition
,
and
immune
dysfunction
typical
of
LPDs
is
still
unclear
.
We
retrospectively
studied
230
patients
with
Waldenström
macroglobulinemia
(
WM
)
to
assess
the
frequency
,
characteristics
,
and
predictive
factors
of
second
cancers
and
to
evaluate
whether
patients
with
WM
are
at
higher
risk
of
second
cancers
compared
with
an
age-
and
sex-matched
control
population
.
In
a
competing-risk
model
,
the
cumulative
incidence
of
solid
cancers
was
6
%
at
5
years
,
11
%
at
10
years
,
and
17
%
at
15
years
,
whereas
the
incidence
of
hematologic
malignancies
was
4
%
at
5
years
,
7
%
at
10
years
,
and
8
%
at
15
years
.
Compared
with
an
age-
and
sex-matched
population
,
the
overall
risk
of
second
cancers
was
1
.
7
-
fold
higher
than
expected
(
95
%
confidence
interval
[
CI
]
,
1
.
22
-
2
.
38
;
P
Â
=
.
002
)
.
Patients
with
WM
were
at
increased
risk
for
diffuse
large
B-
cell
lymphoma
(
DLBCL
)
(
standardized
incidence
ratio
[
SIR
]
,
8
.
64
;
95
%
CI
,
3
.
88
-
19
.
22
;
P
Â
<
.
0001
)
,
myelodysplastic
syndrome
/
acute
myeloid
leukemia
(
MDS
/
AML
)
(
SIR
9
.
5
;
95
%
CI
,
3
.
6
-
25
.
3
;
P
Â
<
.
0001
)
,
and
brain
cancer
(
SIR
,
7
.
59
;
95
%
CI
,
1
.
9
-
30
.
4
;
P
Â
<
.
0001
)
.
The
risk
of
a
second
hematologic
malignancy
was
5
-
fold
higher
in
treated
than
in
untreated
patients
(
P
Â
=
.
08
)
.
Patients
with
WM
are
at
increased
risk
of
DLBCL
,
MDS
/
AML
,
and
brain
cancers
compared
with
the
general
population
.
Further
studies
are
needed
to
clarify
whether
the
increased
incidence
of
second
cancers
is
related
to
treatments
,
to
the
immunologic
impairment
associated
with
the
disease
,
or
to
genetic
predisposition
.
Diseases
Validation
Diseases presenting
"brain cancer"
symptom
oral submucous fibrosis
waldenström macroglobulinemia
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom